rs41463049

chr2-162273520-G-T

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_Strong BP6_Moderate BA1

The NM_022168.4(IFIH1):c.2454+275C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.035 in 152,210 control chromosomes in the GnomAD database, including 457 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

• Frequency: Genomes: 𝑓 0.035 (457 hom., cov: 32)
• Consequence: IFIH1 NM_022168.4 intron
• Clinical Significance: Likely benign criteria provided, single submitter B:1
• Conservation: PhyloP100: 0.0270

Genes affected

IFIH1 (HGNC:18873): (interferon induced with helicase C domain 1) IFIH1 encodes MDA5 which is an intracellular sensor of viral RNA that triggers the innate immune response. Sensing RNA length and secondary structure, MDA5 binds dsRNA oligonucleotides with a modified DExD/H-box helicase core and a C-terminal domain, thus leading to a proinflammatory response that includes interferons. It has been shown that Coronaviruses (CoVs) as well as various other virus families, are capable of evading the MDA5-dependent interferon response, thus impeding the activation of the innate immune response to infection. MDA5 has also been shown to play an important role in enhancing natural killer cell function in malaria infection. In addition to its protective role in antiviral responses, MDA5 has been implicated in autoimmune and autoinflammatory diseases such as type 1 diabetes, systemic lupus erythematosus, and Aicardi-Goutieres syndrome[provided by RefSeq, Jul 2020]

ACMG classification

Verdict is Benign. Variant got -14 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.88).
• BP6: Variant 2-162273520-G-T is Benign according to our data. Variant chr2-162273520-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 1300763.Status of the report is criteria_provided_single_submitter, 1 stars.
• BA1: GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.203 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
IFIH1	NM_022168.4	c.2454+275C>A		intron_variant		ENST00000649979.2
IFIH1	XM_047445407.1	c.1737+275C>A		intron_variant

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
IFIH1	ENST00000649979.2	c.2454+275C>A		intron_variant			NM_022168.4	P1

Frequencies

GnomAD3 genomes AF: 0.0348 AC: 5290 AN: 152092 Hom.: 443 Cov.: 32

Gnomad AFR AF: 0.00695

Gnomad AMI AF: 0.00987

Gnomad AMR AF: 0.208

Gnomad ASJ AF: 0.00577

Gnomad EAS AF: 0.124

Gnomad SAS AF: 0.0222

Gnomad FIN AF: 0.0120

Gnomad MID AF: 0.00

Gnomad NFE AF: 0.0122

Gnomad OTH AF: 0.0460

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.0350 AC: 5321 AN: 152210 Hom.: 457 Cov.: 32 AF XY: 0.0377 AC XY: 2807 AN XY: 74426

Gnomad4 AFR AF: 0.00693

Gnomad4 AMR AF: 0.209

Gnomad4 ASJ AF: 0.00577

Gnomad4 EAS AF: 0.123

Gnomad4 SAS AF: 0.0224

Gnomad4 FIN AF: 0.0120

Gnomad4 NFE AF: 0.0122

Gnomad4 OTH AF: 0.0526

Alfa AF: 0.0497 Hom.: 131

Bravo AF: 0.0528

Asia WGS AF: 0.105 AC: 362 AN: 3478

ClinVar

Significance: Likely benign

Submissions summary: Benign:1

Revision: criteria provided, single submitter

Submissions by phenotype

not provided Benign:1

Likely benign, criteria provided, single submitter

clinical testing

GeneDx

Apr 08, 2021

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.88
Cadd	Benign	0.92
Dann	Benign	0.45

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.010		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs41463049; hg19: chr2-163130030;